OrrLab
@Orr_Lab
Followers
274
Following
122
Media
4
Statuses
70
Orr Lab at WashU | PI: Miranda Orr, PhD | Lab Interests: Aging, Alzheimer's disease, Neurodegenerative disorders, Tau, and Senescence
St. Louis, MO
Joined April 2021
RT @TheADDF: Congratulations to the 10 Goodes Prize winners who along with the ADDF have shaped the last decade of #Alzheimers research aro….
0
1
0
RT @nanostringtech: NanoString is excited to announce it will be acquired by Bruker Corporation in a $392.6 million agreement. We are grate….
0
17
0
RT @CTADconference: Thank you @TheADDF for bringing together at#ADPD2024 this impactful roundtable on Novel Approches in AD Research guided….
0
1
0
RT @hoheyn: .@nanostringtech is here to stay!. Joe Beechem speaks up @GENbio: .“We are not going anywhere”. Only #diversity will drive….
0
13
0
RT @bess_frost: It has been fun working with @RCFNeuro, @alzassociation, @CurePSP and other organizers to develop the scientific program fo….
0
5
0
Thrilled to help @jme_walker and her team explore differences in NFTs between #PART and #AD using GeoMx DSP! Awesome work! #nanostrung.
#Spatialproteomics reveal mechanisms of development and progression in #Alzheimer'sdisease. 🧠 👉 @Orr_lab from Wake Forest University used GeoMx DSP to show proteome differences at the basis of Aβ and p-tau distribution and pathogenicity. #Fridayread
0
2
12
RT @jme_walker: Happy to share our latest publication - we used spatial proteomics to compare #PART and #AD looking at differences between….
0
6
0
RT @wakeforestmed: 🧟 The @Orr_Lab is researching senescent cells and their impact on memory problems. Could targeting "zombie" cells be a b….
0
3
0
RT @TheADDF: ADDF-funded @Orr_Lab's #CombinationTherapy clinical trial on senescent cells supports the ADDF's core belief that the next gen….
0
3
0
RT @TheADDF: Last week's 9th Annual Melvin R. Goodes Prize Luncheon & symposium reflected on recent breakthroughs in #Alzheimers research.….
0
3
0
RT @NatureMedicine: First feasibility study of orally-delivered #senolytic therapy in #Alzheimersdisease reports favorable safety data and….
0
7
0
RT @wakeforestmed: Research from @Orr_Lab shows that treatment to clear #senescent cells in #Alzheimer’s disease is safe in Phase I clinica….
0
5
0
RT @TheADDF: Results from a new study led by ADDF-funded @Orr_Lab further validate that novel approaches to #Alzheimers centered around the….
0
5
0
Exciting news! Led by @MitziGonzales, our team’s Phase I trial testing #senolytics in #Alzheimer’s disease reports on brain penetrance, safety, and biomarkers! 🧠 Phase 2 trial supported by @TheADDF is underway! #JoinOurStudy #SToMP-AD #Senescence #Aging
1
10
20
RT @jme_walker: A fun day 1 at #AAIC23 with @theREALaivisaur @bbonakda @MaggieFlanagan @Orr_Lab @JohnCraryMDPHD ☺️🧠🍨
0
5
0
RT @NathanShockCtrs: Thank you to all who joined the NSC Directors Symposium at #AGE2023!.The session featured presentations from pilot gra….
0
4
0
RT @TheADDF: More than 6.7M Americans and 57M people worldwide are living with #Alzheimers today. A new gift from the #Lauders ensures the….
0
11
0
RT @TheADDF: Within the next 15 years, ADDF will help bring to market a new generation of drugs based on the #biologyofaging that can be co….
0
6
0